Shares of DIAGNOS Inc. (CVE:ADK – Get Free Report) were down 9.2% during trading on Monday . The company traded as low as C$0.35 and last traded at C$0.35. Approximately 109,454 shares changed hands during mid-day trading, an increase of 19% from the average daily volume of 92,220 shares. The stock had previously closed at C$0.38.
Wall Street Analyst Weigh In
Separately, Ventum Cap Mkts upgraded DIAGNOS to a “strong-buy” rating in a report on Wednesday, July 17th.
View Our Latest Stock Report on ADK
DIAGNOS Trading Down 9.2 %
DIAGNOS (CVE:ADK – Get Free Report) last announced its earnings results on Wednesday, August 21st. The company reported C($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C($0.02) by C$0.01. The firm had revenue of C$0.04 million during the quarter, compared to analysts’ expectations of C$0.07 million. Equities analysts forecast that DIAGNOS Inc. will post -0.02 earnings per share for the current year.
About DIAGNOS
DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.
Recommended Stories
- Five stocks we like better than DIAGNOS
- Financial Services Stocks Investing
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- The 3 Best Blue-Chip Stocks to Buy Now
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.